top of page
Insilico Medicine Investment Universe Dashboard
A comprehensive Insilico Medicine Investment Universe Dashboard provides a detailed exploration of investment activities, entities, and interactions within the pharmaceutical and biotech industry. The dashboard features tools for analyzing SWOT comparisons, competitors, investment funds, and funding rounds. It emphasizes AI-driven drug discovery and investment dynamics in the pharma sector.
45 Operational Environment Companies
80
R&D Pipeline Analyzed
75
Analyzed Financial Deals
200+
Investment Rounds since 2022
Operational Environment: Insilico Medicine Overview
Key Metrics:
-
$895M last funding round valuation, $1.5B conservative scenario valuation, and $2B optimistic valuation.
-
Total funding raised: $424M.
-
Capitalization prospects exceed $2.5B, with $51.2M projected revenue in 2023.
Key Features:
-
Radar Chart: Compares Insilico Medicine with competitors like BenevolentAI, Owkin, and Schrödinger across parameters such as team assessment, product, marketing, AI/ML capabilities, and financial performance.
-
AI Pharma Universe: A circular visualization mapping AI companies, investors, hubs, and corporations within the pharma sector.
Explore other Dashboards
bottom of page